Beyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis

医学 列线图 比例危险模型 组织学 内科学 阶段(地层学) 肿瘤科 佐剂 放射治疗 风险因素 癌症 宫颈癌 生物 古生物学
作者
Kimberly Levinson,Anna Beavis,Christopher Purdy,Anne F. Rositch,Akila N. Viswanathan,Aaron H. Wolfson,Michael Kelly,Krishnansu S. Tewari,Leah McNally,Saketh R. Guntupalli,Omar Ragab,Yi-Chun Lee,David S. Miller,Warner K. Huh,Kelly J. Wilkinson,Nicola M. Spirtos,Linda Van Le,Yovanni Casablanca,Laura L. Holman,Steven Waggoner
出处
期刊:Gynecologic Oncology [Elsevier BV]
卷期号:162 (3): 532-538 被引量:44
标识
DOI:10.1016/j.ygyno.2021.06.017
摘要

The Sedlis criteria define risk factors for recurrence warranting post-hysterectomy radiation for early-stage cervical cancer; however, these factors were defined for squamous cell carcinoma (SCC) at an estimated recurrence risk of ≥30%. Our study evaluates and compares risk factors for recurrence for cervical SCC compared with adenocarcinoma (AC) and develops histology-specific nomograms to estimate risk of recurrence and guide adjuvant treatment.We performed an ancillary analysis of GOG 49, 92, and 141, and included stage I patients who were surgically managed and received no neoadjuvant/adjuvant therapy. Multivariable Cox proportional hazards models were used to evaluate independent risk factors for recurrence by histology and to generate prognostic histology-specific nomograms for 3-year recurrence risk.We identified 715 patients with SCC and 105 with AC; 20% with SCC and 17% with AC recurred. For SCC, lymphvascular space invasion (LVSI: HR 1.58, CI 1.12-2.22), tumor size (TS ≥4 cm: HR 2.67, CI 1.67-4.29), and depth of invasion (DOI; middle 1/3, HR 4.31, CI 1.81-10.26; deep 1/3, HR 7.05, CI 2.99-16.64) were associated with recurrence. For AC, only TS ≥4 cm, was associated with recurrence (HR 4.69, CI 1.25-17.63). For both histologies, there was an interaction effect between TS and LVSI. For those with SCC, DOI was most associated with recurrence (16% risk); for AC, TS conferred a 15% risk with negative LVSI versus a 25% risk with positive LVSI.Current treatment standards are based on the Sedlis criteria, specifically derived from data on SCC. However, risk factors for recurrence differ for squamous cell and adenocarcinoma of the cervix. Histology-specific nomograms accurately and linearly represent risk of recurrence for both SCC and AC tumors and may provide a more contemporary and tailored tool for clinicians to base adjuvant treatment recommendations to their patients with cervical cancer.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
cindywu发布了新的文献求助10
2秒前
4秒前
4秒前
5秒前
kaoyikaoli发布了新的文献求助10
5秒前
Newt完成签到,获得积分10
5秒前
我不是财神完成签到 ,获得积分10
9秒前
yar给fishfun的求助进行了留言
9秒前
wanci应助薇薇采纳,获得10
9秒前
YYYZZX1发布了新的文献求助10
9秒前
湛湛发布了新的文献求助10
10秒前
奥特超曼应助刘芮采纳,获得10
10秒前
高挑的涛发布了新的文献求助10
11秒前
木光发布了新的文献求助10
11秒前
粘豆包完成签到,获得积分10
12秒前
今后应助noss采纳,获得30
13秒前
莫之玉完成签到 ,获得积分20
13秒前
平常的元蝶完成签到 ,获得积分10
13秒前
Abby发布了新的文献求助10
14秒前
14秒前
chayue完成签到 ,获得积分10
15秒前
张光光完成签到,获得积分10
15秒前
17秒前
张光光发布了新的文献求助10
19秒前
情怀应助逃跑快人一步采纳,获得10
20秒前
20秒前
20秒前
fsrm完成签到,获得积分10
21秒前
22秒前
123发布了新的文献求助20
23秒前
23秒前
薇薇发布了新的文献求助10
23秒前
24秒前
今后应助桀桀桀采纳,获得10
24秒前
zwc发布了新的文献求助10
24秒前
量子星尘发布了新的文献求助10
24秒前
XYN1发布了新的文献求助10
24秒前
25秒前
siyan156发布了新的文献求助10
26秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988920
求助须知:如何正确求助?哪些是违规求助? 3531290
关于积分的说明 11253247
捐赠科研通 3269903
什么是DOI,文献DOI怎么找? 1804830
邀请新用户注册赠送积分活动 882027
科研通“疑难数据库(出版商)”最低求助积分说明 809052